GANX

Gain Therapeutics Stock Price

8.00
-0.20 (-2.44%)
Upgrade to Real-Time
Afterhours (Closed)
8.00

Low
7.64

52 Week Range

High
17.93

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Gain Therapeutics Inc GANX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.20 -2.44% 8.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
8.36 7.71 8.40 8.00 8.20
Bid Price Ask Price Spread News
7.00 15.00 8.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
631 32,104 $ 8.15 $ 261,569 - 7.64 - 17.93
Last Trade Time Type Quantity Stock Price Currency
16:00:00 132 $ 8.00 USD

Period:

Draw Mode:

Gain Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 95.01M 11.88M 10.78M $ 28.88k $ - -0.61 -8.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 1.80%

more financials information »

Gain Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GANX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.189.187.648.3818,199-1.18-12.85%
1 Month10.1810.40897.649.1416,109-2.18-21.41%
3 Months11.0411.127.649.7328,480-3.04-27.54%
6 Months11.2217.937.6412.0269,592-3.22-28.7%
1 Year11.2217.937.6412.0269,592-3.22-28.7%
3 Years11.2217.937.6412.0269,592-3.22-28.7%
5 Years11.2217.937.6412.0269,592-3.22-28.7%

Gain Therapeutics Description

Gain Therapeutics Inc is a development-stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders (LSDs), including rare genetic diseases and neurological disorders. Its pipeline includes the GLB1 gene, GBA1 gene, IDUA gene, and GALC gene.


Your Recent History
NASDAQ
GANX
Gain Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.